Benzinga | May 7, 2021 06:51AM EDT

ANI Pharmaceuticals Q1 EPS $1.04 Beats $0.71 Estimate, Sales $54.50M Beat $46.80M Estimate

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.71 by 46.48 percent. This is unchanged from the same period last year. The company reported quarterly sales of $54.50 million which beat the analyst consensus estimate of $46.80 million by 16.45 percent. This is a 9.49 percent increase over sales of $49.77 million the same period last year.